Yeztugo Disease Interactions
There are 2 disease interactions with Yeztugo (lenacapavir).
Moderate
Lenacapavir (applies to Yeztugo) liver dysfunction
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
Lenacapavir has not been studied in patients with severe hepatic impairment (Child-Pugh Class C).
Moderate
Lenacapavir (applies to Yeztugo) renal dysfunction
Moderate Potential Hazard, Moderate plausibility.
Lenacapavir has not been studied in patients with end stage renal disease (estimated creatinine clearance less than 15 mL per minute).
Switch to professional interaction data
Yeztugo drug interactions
There are 472 drug interactions with Yeztugo (lenacapavir).
Report options
QR code containing a link to this page
More about Yeztugo (lenacapavir)
- Yeztugo consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antivirals
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
